President and CEO of Seattle Genetics, Inc. (SGEN, Financial) Clay B Siegall sells 8,250 shares of SGEN on 12/03/2012 at an average price of $25.19 a share.
Seattle Genetics, Inc. has a market cap of $3.01 billion; its shares were traded at around $26.01 with and P/S ratio of 31.6. Seattle Genetics, Inc. had an annual average earning growth of 3.2% over the past 10 years. GuruFocus rated Seattle Genetics, Inc. the business predictability rank of 3-star.
For the complete insider trading history of SGEN, click here.
Seattle Genetics, Inc. has a market cap of $3.01 billion; its shares were traded at around $26.01 with and P/S ratio of 31.6. Seattle Genetics, Inc. had an annual average earning growth of 3.2% over the past 10 years. GuruFocus rated Seattle Genetics, Inc. the business predictability rank of 3-star.
CEO Recent Trades:
- President and CEO Clay B Siegall sold 8,250 shares of SGEN stock on 12/03/2012 at the average price of 25.19. Clay B Siegall owns at least 1,170,961 shares after this. The price of the stock has increased by 3.26% since.
- President and CEO Clay B Siegall sold 8,250 shares of SGEN stock on 11/01/2012 at the average price of 25.51. Clay B Siegall owns at least 1,170,961 shares after this. The price of the stock has increased by 1.96% since.
- President and CEO Clay B Siegall sold 8,250 shares of SGEN stock on 10/01/2012 at the average price of 26.59. Clay B Siegall owns at least 1,170,961 shares after this. The price of the stock has decreased by 2.18% since.
- President and CEO Clay B Siegall sold 8,250 shares of SGEN stock on 09/04/2012 at the average price of 26.54. Clay B Siegall owns at least 1,170,961 shares after this. The price of the stock has decreased by 2% since.
- President and CEO Clay B Siegall sold 8,250 shares of SGEN stock on 08/02/2012 at the average price of 26. Clay B Siegall owns at least 1,096,711 shares after this. The price of the stock has increased by 0.04% since.
CFO Recent Trades:
- CFO Todd E Simpson sold 95,000 shares of SGEN stock on 09/06/2012 at the average price of 28.5. Todd E Simpson owns at least 70,762 shares after this. The price of the stock has decreased by 8.74% since.
- CFO Todd E Simpson sold 45,000 shares of SGEN stock on 08/27/2012 at the average price of 26.97. Todd E Simpson owns at least 70,762 shares after this. The price of the stock has decreased by 3.56% since.
- CFO Todd E Simpson sold 40,000 shares of SGEN stock on 08/16/2012 at the average price of 25.97. Todd E Simpson owns at least 50,762 shares after this. The price of the stock has increased by 0.15% since.
- CFO Todd E Simpson sold 95,000 shares of SGEN stock on 06/14/2012 at the average price of 24.5. Todd E Simpson owns at least 50,762 shares after this. The price of the stock has increased by 6.16% since.
- CFO Todd E Simpson sold 35,000 shares of SGEN stock on 06/08/2012 at the average price of 22.97. Todd E Simpson owns at least 50,762 shares after this. The price of the stock has increased by 13.23% since.
Directors and Officers Recent Trades:
- Chief Medical Officer Thomas C Reynolds sold 40,000 shares of SGEN stock on 12/03/2012 at the average price of 25.41. Thomas C Reynolds owns at least 57,601 shares after this. The price of the stock has increased by 2.36% since.
- Chief Medical Officer Thomas C Reynolds sold 30,000 shares of SGEN stock on 11/26/2012 at the average price of 25.34. Thomas C Reynolds owns at least 57,601 shares after this. The price of the stock has increased by 2.64% since.
- Chief Medical Officer Thomas C Reynolds sold 20,000 shares of SGEN stock on 11/20/2012 at the average price of 24.95. Thomas C Reynolds owns at least 57,601 shares after this. The price of the stock has increased by 4.25% since.
- COO Eric Dobmeier sold 27,327 shares of SGEN stock on 11/13/2012 at the average price of 23.59. Eric Dobmeier owns at least 101,411 shares after this. The price of the stock has increased by 10.26% since.
- COO Eric Dobmeier sold 25,000 shares of SGEN stock on 10/15/2012 at the average price of 25.01. Eric Dobmeier owns at least 69,352 shares after this. The price of the stock has increased by 4% since.
For the complete insider trading history of SGEN, click here.
